The significance of spliceosome mutations in chronic lymphocytic leukemia.
The significance of spliceosome mutations in chronic lymphocytic leukemia.
复制标题
DOI:
10.3109/10428194.2012.742528
复制
发表时间:
2013-07
影响因子:
2.6
通讯作者:
Estrov Z
中科院分区:
文献类型:
--
作者:
Rozovski U;Keating M;Estrov Z
Cellular proteins produced via alternative splicing, provide neoplastic cells with survival advantage and/or promote neoplastic cell proliferation. Pre-mRNA is spliced by the spliceosome consisting of large complexes of small nuclear RNA (snRNA) and protein subunits. Spliceosome gene mutations were detected in 40 – 80% of patients with myelodysplastic syndrome (MDS), particularly in those with ringed sideroblasts. Recently, two large whole genome sequencing studies identified mutations in the spliceosome gene SF3B1 in approximately 10% of patients with chronic lymphocytic leukemia (CLL). Intrigued by these findings, we performed a pathway enrichment analysis and found that unlike in MDS, in CLL spliceosome mutations exist almost exclusively in SF3B1. CLL patients with an SF3B1 gene mutation are characterized by a short progression-free survival and a low 10 year-survival rate. Furthermore, the frequency of SF3B1 mutations is significantly higher in chemotherapy treated than in untreated patients with CLL, suggesting that chemotherapy induces SF3B1 gene mutations or selects a population of mutated cells. Whether SF3B1 gene mutations have a role in leukemogenesis, either because of altered splicing or other splicing-unrelated functions such as ectopic expression of Homobox (Hox) genes previously reported in SF3B1+/- mice, remains to be determined.
登录
查看更多内容
影响因子:
64.8
作者:
Ellis, Matthew J.;Ding, Li;Shen, Dong;Luo, Jingqin;Suman, Vera J.;Wallis, John W.;Van Tine, Brian A.;Hoog, Jeremy;Goiffon, Reece J.;Goldstein, Theodore C.;Ng, Sam;Lin, Li;Crowder, Robert;Snider, Jacqueline;Ballman, Karla;Weber, Jason;Chen, Ken;Koboldt, Daniel C.;Kandoth, Cyriac;Schierding, William S.;McMichael, Joshua F.;Miller, Christopher A.;Lu, Charles;Harris, Christopher C.;McLellan, Michael D.;Wendl, Michael C.;DeSchryver, Katherine;Allred, D. Craig;Esserman, Laura;Unzeitig, Gary;Margenthaler, Julie;Babiera, G. V.;Marcom, P. Kelly;Guenther, J. M.;Leitch, Marilyn;Hunt, Kelly;Olson, John;Tao, Yu;Maher, Christopher A.;Fulton, Lucinda L.;Fulton, Robert S.;Harrison, Michelle;Oberkfell, Ben;Du, Feiyu;Demeter, Ryan;Vickery, Tammi L.;Elhammali, Adnan;Piwnica-Worms, Helen;McDonald, Sandra;Watson, Mark;Dooling, David J.;Ota, David;Chang, Li-Wei;Bose, Ron;Ley, Timothy J.;Piwnica-Worms, David;Stuart, Joshua M.;Wilson, Richard K.;Mardis, Elaine R.
通讯作者:
Mardis, Elaine R.
DOI:
10.1056/nejmoa1103283
发表时间:
2011-10-13
期刊:
The New England journal of medicine
影响因子:
--
作者:
Papaemmanuil E;Cazzola M;Boultwood J;Malcovati L;Vyas P;Bowen D;Pellagatti A;Wainscoat JS;Hellstrom-Lindberg E;Gambacorti-Passerini C;Godfrey AL;Rapado I;Cvejic A;Rance R;McGee C;Ellis P;Mudie LJ;Stephens PJ;McLaren S;Massie CE;Tarpey PS;Varela I;Nik-Zainal S;Davies HR;Shlien A;Jones D;Raine K;Hinton J;Butler AP;Teague JW;Baxter EJ;Score J;Galli A;Della Porta MG;Travaglino E;Groves M;Tauro S;Munshi NC;Anderson KC;El-Naggar A;Fischer A;Mustonen V;Warren AJ;Cross NC;Green AR;Futreal PA;Stratton MR;Campbell PJ;Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
通讯作者:
Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
影响因子:
3.7
作者:
Harris DM;Hazan-Haley I;Coombes K;Bueso-Ramos C;Liu J;Liu Z;Li P;Ravoori M;Abruzzo L;Han L;Singh S;Sun M;Kundra V;Kurzrock R;Estrov Z
通讯作者:
Estrov Z
影响因子:
20.3
作者:
Rossi, Davide;Bruscaggin, Alessio;Gaidano, Gianluca
通讯作者:
Gaidano, Gianluca
影响因子:
20.3
作者:
Makishima, Hideki;Visconte, Valeria;Maciejewski, Jaroslaw P.
通讯作者:
Maciejewski, Jaroslaw P.